Cyclica

Cyclica is a company that develops drugs with an AI-enabled platform. It has partnered with ATAI Life Sciences and together they have formed EntheogeniX Biosciences.

Cyclica

“Cyclica is a Toronto-based, globally recognized biotechnology company that leverages AI and computational biophysics to reshape drug discovery. Cyclica provides the pharmaceutical industry with an integrated and end-to-end enabling drug discovery platform focused on polypharmacology. Ligand Design and Ligand Express offer a unique AI-augmented platform to design advanced lead-like molecules that minimize unwanted off-target effects, while providing a holistic understanding of a molecule’s activity through integrated systems biology and structural pharmacogenomics. By doing more with AI, Cyclica aims to revolutionize a system troubled with attrition and costly failures, accelerate the drug discovery process, and develop medicines with greater precision.“

News

• Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future (June 2020)